Partnership Opportunities

With 150+ industry leading attendees, Gene Therapy for Ophthalmic Disorders is your opportunity to showcase your products and services, whilst establishing your company as a front runner in the field.

 

Meet industry scientists with the following expertize:

  • Discovery
  • Preclinical
  • Translational
  • Clinical
  • Strategy
  • CSO, CEO, CMO

Who Attended in 2020?

Gene Therapy for Ophthalmic Disorders 2021

Seeking preclinical models and services for:

  • Inherited retinal disorders IRDs
  • Wet age-related macular degeneration (AMD),
  • Dry AMD
  • Diabetic macular edema (DME),
  • Leber hereditary optic neuropathy (LHON)
  • Choroidermia
  • Glaucoma
  • And many more ophthalmic disorders

And other ocular diagnostic, endpoints and delivery technologies.

If you offer any services or products which could support this audience of ophthalmic experts, please get in touch here.